Drug Target Insights
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.7 | Q2 | 66.6% | 0.692 | Q1 | 72.5% |
| 2024 | 2.5 | Q3 | 49.0% | 0.479 | Q2 | 60.9% |
| 2023 | 2.0 | Q3 | 39.5% | 0.429 | Q2 | 59.9% |
| 2022 | 2.7 | 47.1% | 0.690 | Q1 | 76.4% | |
| 2021 | — | 24.0% | 0.365 | Q2 | 57.5% | |
| 2020 | — | — | 0.297 | Q2 | 50.1% | |
| 2019 | — | — | 0.324 | Q2 | 54.9% | |
| 2018 | — | — | 0.310 | Q2 | 51.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1177-3928
country
ITcoverage
2008-2009, 2011-2025